JENNIFER CABALLERO: Open Payments
NPI 1508142803 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,344 in 100 payments from 18 companies in 2025. Trend: 2023 $1,048 · 2024 $1,573 · 2025 $2,344
Food & beverage: $2,228Education: $116
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $332 |
| Regeneron Healthcare Solutions, Inc. | 9 | $311 |
| United Therapeutics Corporation | 8 | $241 |
| Insmed, Inc. | 10 | $235 |
| GENZYME CORPORATION | 5 | $173 |
| Actelion Pharmaceuticals US, Inc. | 4 | $149 |
| Grifols USA, LLC | 5 | $134 |
| Verona Pharma, Inc. | 5 | $131 |
| Merck Sharp & Dohme LLC | 5 | $125 |
| Electromed, Inc. | 10 | $113 |
Products named: DUPIXENT, Arikayce, NUCALA, Ohtuvayre, TRELEGY ELLIPTA, OPSUMIT, Tyvaso, SMARTVEST.
Industry payments across FL — which companies pay providers there.
